LataMed AI evaluates integration with Cashea buy-now-pay-later platform to reduce healthcare costs. Learn how installment payments could boost patient access inLataMed AI evaluates integration with Cashea buy-now-pay-later platform to reduce healthcare costs. Learn how installment payments could boost patient access in

LataMed AI Evaluates Integration of Installment Payments via Cashea to Improve Healthcare Access in Venezuela

2026/06/11 20:55
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on emerging markets, announced it has initiated an evaluation process to integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services within the LataMed AI ecosystem.

By enabling patients to pay for consultations, diagnostics, wellness programs, and other eligible healthcare offerings over time, the company hopes to increase patient engagement, healthcare utilization, and platform adoption. Management believes that addressing affordability is key to expanding access to private healthcare in Latin America, where out-of-pocket costs often deter timely medical care.

Dr. Kevin Rodan Levy, CEO of LataMed AI, stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem.” He added that such initiatives could strengthen patient acquisition and support long-term platform growth.

The proposed integration is part of LataMed AI’s broader strategy to combine artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility into a scalable healthcare marketplace. The company has not yet entered into a definitive commercial agreement, and completion of any integration remains subject to further discussions, technical implementation, regulatory review, and customary business conditions.

LataMed AI, which is traded on the OTC market, develops technology platforms designed to support healthcare access, patient engagement, provider coordination, and data-driven operations, with an initial focus on Latin America. The company’s SEC filings are available at www.sec.gov.

The news underscores a growing trend of fintech-healthcare convergence in emerging markets, where innovative payment solutions are being used to bridge gaps in healthcare affordability. For LataMed AI, a successful partnership with Cashea could differentiate its platform in a competitive landscape and drive adoption among price-sensitive patients. However, the company faces risks common to development-stage firms, including financing, regulatory hurdles, and operational execution in Venezuela’s challenging economic environment.

Investors should note that forward-looking statements in the release are subject to risks outlined in the company’s SEC filings, and no assurance can be given that the integration will materialize. LataMed AI intends to provide updates as developments occur.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is LataMed AI Evaluates Integration of Installment Payments via Cashea to Improve Healthcare Access in Venezuela.

The post LataMed AI Evaluates Integration of Installment Payments via Cashea to Improve Healthcare Access in Venezuela appeared first on citybuzz.

Market Opportunity
Gensyn Logo
Gensyn Price(AI)
$0.02777
$0.02777$0.02777
-0.57%
USD
Gensyn (AI) Live Price Chart

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage